EP1420808A4 - Traitement de la tuberculose au moyen de composes immunomodulateurs - Google Patents

Traitement de la tuberculose au moyen de composes immunomodulateurs

Info

Publication number
EP1420808A4
EP1420808A4 EP01271057A EP01271057A EP1420808A4 EP 1420808 A4 EP1420808 A4 EP 1420808A4 EP 01271057 A EP01271057 A EP 01271057A EP 01271057 A EP01271057 A EP 01271057A EP 1420808 A4 EP1420808 A4 EP 1420808A4
Authority
EP
European Patent Office
Prior art keywords
tuberculosis
treatment
immunomodulator compounds
immunomodulator
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01271057A
Other languages
German (de)
English (en)
Other versions
EP1420808A1 (fr
Inventor
Alexander A Kolobov
Andrey S Simbirtsev
Tat Yana I Vinogradova
Natal Ya V Zabolotnyh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sciclone Pharmaceuticals LLC
Original Assignee
Sciclone Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals LLC filed Critical Sciclone Pharmaceuticals LLC
Priority to EP09000806A priority Critical patent/EP2078525A3/fr
Publication of EP1420808A1 publication Critical patent/EP1420808A1/fr
Publication of EP1420808A4 publication Critical patent/EP1420808A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP01271057A 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composes immunomodulateurs Withdrawn EP1420808A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09000806A EP2078525A3 (fr) 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composés immunomodulateurs

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2001115900/14A RU2229892C2 (ru) 2001-06-08 2001-06-08 Способ лечения туберкулеза легких
RU2001115900 2001-08-06
PCT/US2001/048560 WO2003013572A1 (fr) 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composes immunomodulateurs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP09000806A Division EP2078525A3 (fr) 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composés immunomodulateurs

Publications (2)

Publication Number Publication Date
EP1420808A1 EP1420808A1 (fr) 2004-05-26
EP1420808A4 true EP1420808A4 (fr) 2006-06-07

Family

ID=20250617

Family Applications (2)

Application Number Title Priority Date Filing Date
EP01271057A Withdrawn EP1420808A4 (fr) 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composes immunomodulateurs
EP09000806A Withdrawn EP2078525A3 (fr) 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composés immunomodulateurs

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP09000806A Withdrawn EP2078525A3 (fr) 2001-06-08 2001-12-20 Traitement de la tuberculose au moyen de composés immunomodulateurs

Country Status (4)

Country Link
EP (2) EP1420808A4 (fr)
JP (1) JP4837251B2 (fr)
RU (1) RU2229892C2 (fr)
WO (1) WO2003013572A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964731A (zh) * 2004-05-14 2007-05-16 希克龙制药公司 用免疫调节剂化合物治疗或预防呼吸道病素性感染
US20090074815A1 (en) * 2005-04-22 2009-03-19 Sciclone Pharmaceuticals, Inc. Immunomodulator Compounds as Vaccine Enhancers
EP2120986A4 (fr) 2007-02-13 2010-04-07 Sciclone Pharmaceuticals Inc Procédé de traitement ou de prévention de la détérioration des tissus, des blessures ou des dégâts dus à une maladie de la muqueuse
CN101842009A (zh) * 2007-08-23 2010-09-22 赛生制药有限公司 肺癌的治疗
RU2450820C2 (ru) * 2010-07-20 2012-05-20 Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) Способ лечения деструктивного туберкулеза легких

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020063A2 (fr) * 1993-03-04 1994-09-15 Cytoven International N.V. Tryptophane pharmaceutique contenant des compositions dipeptidiques et modes d'utilisation
WO1997019691A1 (fr) * 1995-11-28 1997-06-05 Wei, Edward, T. Composes immunomodulateurs contenant du gamma-l-glutamyl et procedes afferents
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US6060452A (en) * 1996-03-13 2000-05-09 Cytran, Inc. Analogs of L-Glu-L-Trp having pharmacological activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520196A (en) * 1983-08-18 1985-05-28 American Home Products Corporation α-Mercaptophenylacetic acid derivatives of imidazole-containing compounds and analogues thereof
US5212192A (en) * 1989-11-24 1993-05-18 Janssen Pharmaceutica N.V. Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives
RU2142958C1 (ru) * 1997-12-25 1999-12-20 Товарищество с ограниченной ответственностью "Верта" Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
RU2120298C1 (ru) * 1995-11-28 1998-10-20 Товарищество с ограниченной ответственностью "Верта" Иммуностимулятор и препарат на его основе
ATE214936T1 (de) * 1995-12-14 2002-04-15 Novelos Therapeutics Inc Oxidiertes glutathion als mittel zur verbesserung der endogenen produktion von cytokinen und haematopoietischen faktoren

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020063A2 (fr) * 1993-03-04 1994-09-15 Cytoven International N.V. Tryptophane pharmaceutique contenant des compositions dipeptidiques et modes d'utilisation
WO1997019691A1 (fr) * 1995-11-28 1997-06-05 Wei, Edward, T. Composes immunomodulateurs contenant du gamma-l-glutamyl et procedes afferents
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US6060452A (en) * 1996-03-13 2000-05-09 Cytran, Inc. Analogs of L-Glu-L-Trp having pharmacological activity

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BIOCENTURY, 8(10, PT. 2), P. B13. ISSN: 1097-7201; CODEN: BICEFS., 28 February 2000 (2000-02-28) *
BUCHAN G.S. ET AL: "Tuberculosis in domesticated deer cervus-elaphus a large anumal model for tuberculosis", JOURNAL OF COMPARATIVE PATHOLOGY, vol. 103, no. 1, 1990, pages 11 - 22 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1990, Database accession no. PREV199090100455 *
DATABASE CIN [online] "Other Research News", XP002377620, retrieved from STN Database accession no. 29(11):11078F *
DATABASE IMSDRUGNEWS [online] R & D Focus Drug News; 22 January 2001 (2001-01-22), XP002377621, retrieved from STN Database accession no. AN = 2001:333 *
DATABASE IMSDRUGNEWS [online] R & D Focus Drug News; 6 September 1999 (1999-09-06), XP002377619, retrieved from STN Database accession no. 1999:2565 *
NICOLAUS B.J.R.: "symbiotic approach to drug design", DECISION MAKING IN DRUG RESEARCH, 1983, pages 173 - 186, XP002197412 *
See also references of WO03013572A1 *

Also Published As

Publication number Publication date
WO2003013572A1 (fr) 2003-02-20
JP2004537579A (ja) 2004-12-16
EP2078525A3 (fr) 2010-09-08
EP2078525A2 (fr) 2009-07-15
EP1420808A1 (fr) 2004-05-26
JP4837251B2 (ja) 2011-12-14
RU2229892C2 (ru) 2004-06-10

Similar Documents

Publication Publication Date Title
GB2393202B (en) Methods of well treatment
IL156595A0 (en) Therapeutic heterocyclic compounds
GB0121155D0 (en) Treatment of substrates
GB0109087D0 (en) Treatment of suspensions
GB0211295D0 (en) Treatment of pain
HK1064952A (en) Treatment of tuberculosis using immunomodulator compounds
GB0124124D0 (en) Methods of treatment
IL161748A0 (en) New use for the treatment of gastroesophageal reflux
GB0112216D0 (en) Method of treatment
GB0118892D0 (en) Method of treatment
GB2380481B (en) Means for treatment of atherosclerosis
AU2002255448A1 (en) Treatment of tuberculosis using immunomodulator compounds
GB0100092D0 (en) Treatment of degenerative diseases
AU2002341485A1 (en) Treatment of polyaluminium compounds
EP1451308A4 (fr) Utilisation therapeutique de composes aziridino
AU2003276123A8 (en) Treatment of uveal melanoma
GB0120654D0 (en) Treatment of anemia
GB0118023D0 (en) Treatment of ischemia
GB0229986D0 (en) Treatment of materials
HU0104370D0 (en) Honeyed schnaps of oerseg
GB0104886D0 (en) Treatment of dandruff
GB0104615D0 (en) Treatment of technetium
GB0105097D0 (en) Treatment of technetium
GB0120406D0 (en) Treatment of anemia
TW501476U (en) Improved structure of coffin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1064952

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20060504

17Q First examination report despatched

Effective date: 20061123

17Q First examination report despatched

Effective date: 20061123

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090122

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1064952

Country of ref document: HK